Clinical trial
Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's…
NCT00004101 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00004101 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma |
| Official title | Phase I Trial of Humanized 1D10 Monoclonal Antibody (Hu1D10) In Patients With Relapsed Non-Hodgkin's Lymphoma (NHL) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological |
| Interventions | apolizumab |
| Enrollment | 35 |
| Start date | Nov 1, 1999 |
| Primary completion | Jun 1, 2005 |
| First posted | May 3, 2004 |
| Last update posted | Feb 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: